| scholarly article | Q13442814 |
| P2093 | author name string | Yi Wang | |
| Qing Lu | |||
| Dan Sun | |||
| Rong Luo | |||
| Fang Fang | |||
| Yi Zheng | |||
| Qing Lin | |||
| Li Jiang | |||
| Lan Xiong | |||
| Jiong Qin | |||
| Yong-Hua Cui | |||
| Zhi-Sheng Liu | |||
| Yu-Wu Jiang | |||
| Shui-Zhen Zhou | |||
| Fang-Cheng Cai | |||
| Jia-Qin Wang | |||
| P2860 | cites work | Sleep difficulties in children with Tourette syndrome and chronic tic disorders: A systematic review of characteristics and associated factors | Q92143252 |
| Tics and Tourette Syndrome | Q92250073 | ||
| A Chinese Herbal Formulation, Xiao-Er-An-Shen Decoction, Attenuates Tourette Syndrome, Possibly by Reversing Abnormal Changes in Neurotransmitter Levels and Enhancing Antioxidant Status in Mouse Brain | Q92510510 | ||
| Predictors of the Clinical Course of Tourette Syndrome: A Longitudinal Study | Q92610682 | ||
| ICD-11: Impact on Traditional Chinese Medicine and World Healthcare Systems | Q92614052 | ||
| [Efficacy of clonidine transdermal patch in treatment of moderate to severe tic disorders in children] | Q95361123 | ||
| Clinical course of Tourette syndrome | Q24568060 | ||
| European clinical guidelines for Tourette syndrome and other tic disorders | Q24631050 | ||
| Aripiprazole for the treatment of tic disorders in children: a systematic review and meta-analysis | Q26798265 | ||
| Clinical assessment of Tourette syndrome and tic disorders | Q26825003 | ||
| The effects of Gilles de la Tourette syndrome and other chronic tic disorders on quality of life across the lifespan: a systematic review | Q28071457 | ||
| Acupuncture for Tourette Syndrome: A Systematic Review | Q28072961 | ||
| The pathophysiology of echopraxia/echolalia: relevance to Gilles de la Tourette syndrome | Q28271301 | ||
| European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment | Q28972478 | ||
| Tourette Syndrome in Children: An Updated Review | Q29012887 | ||
| The prevalence of tic disorders for children in China: A systematic review and meta-analysis | Q30248726 | ||
| Histidine decarboxylase deficiency causes tourette syndrome: parallel findings in humans and mice | Q30421144 | ||
| Tics in the Pediatric Population: Pragmatic Management | Q33577672 | ||
| Aripiprazole in children and adolescents with Tourette's disorder: an open-label safety and tolerability study | Q33819964 | ||
| An international perspective on Tourette syndrome: selected findings from 3,500 individuals in 22 countries | Q33916506 | ||
| Comprehensive behavioral intervention to improve occupational performance in children with Tourette disorder | Q44565061 | ||
| Behavior Therapy for Youth With Tourette Disorder | Q46820620 | ||
| Traditional Chinese medicine Ningdong granule: the beneficial effects in Tourette's disorder | Q47401920 | ||
| Sleep, anxiety and psychiatric symptoms in children with Tourette syndrome and tic disorders. | Q47426763 | ||
| Clinical Utility of Screening for Anxiety and Depression in Children with Tourette Syndrome | Q47644323 | ||
| Efficacy and Safety of Deep Brain Stimulation in Tourette Syndrome: The International Tourette Syndrome Deep Brain Stimulation Public Database and Registry | Q47653861 | ||
| Tourette Syndrome and Chronic Tic Disorders: The Clinical Spectrum Beyond Tics | Q47697616 | ||
| A proprietary herbal medicine (5-Ling Granule) for Tourette syndrome: a randomized controlled trial | Q47965242 | ||
| Disease-specific quality of life in young patients with tourette syndrome | Q48313887 | ||
| Review of the evidence for the management of co-morbid Tic disorders in children and adolescents with attention deficit hyperactivity disorder | Q49453288 | ||
| Evolving Applications, Technological Challenges and Future Opportunities in Neuromodulation: Proceedings of the Fifth Annual Deep Brain Stimulation Think Tank | Q49613705 | ||
| Tourette disorder and other tic disorders | Q50081309 | ||
| Clinical observation on treatment of Tourette syndrome in Chinese children by clonidine adhesive patch. | Q50553416 | ||
| Explosive outbursts in children with Tourette's disorder. | Q51074831 | ||
| A multi-centre, randomised, open-label study of atomoxetine compared with standard current therapy in UK children and adolescents with attention-deficit/hyperactivity disorder (ADHD). | Q51581644 | ||
| European clinical guidelines for Tourette syndrome and other tic disorders. Part III: behavioural and psychosocial interventions | Q34174033 | ||
| European clinical guidelines for Tourette syndrome and other tic disorders. Part IV: deep brain stimulation | Q34174038 | ||
| Canadian guidelines for the evidence-based treatment of tic disorders: pharmacotherapy. | Q34259426 | ||
| Prevalence of tic disorders: a systematic review and meta-analysis | Q34285760 | ||
| Histamine and histamine receptors in Tourette syndrome and other neuropsychiatric conditions | Q34489848 | ||
| Treatment-refractory Tourette Syndrome. | Q34514034 | ||
| The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity | Q34541374 | ||
| Tourette syndrome is not caused by mutations in the central cannabinoid receptor (CNR1) gene | Q34547395 | ||
| The neural circuits that generate tics in Tourette's syndrome. | Q34582801 | ||
| Efficacy and safety of acupuncture in children: an overview of systematic reviews | Q34669708 | ||
| European clinical guidelines for Tourette syndrome and other tic disorders. Part I: assessment | Q34729366 | ||
| Tourette Syndrome: a general pediatrician's 35-year experience at a single center with follow-up in adulthood | Q35182509 | ||
| Psychiatric comorbidities in children with attention deficit hyperactivity disorder: implications for management | Q35568743 | ||
| Current state and recent developments of child psychiatry in China | Q35599580 | ||
| Lifetime prevalence, age of risk, and genetic relationships of comorbid psychiatric disorders in Tourette syndrome | Q35655222 | ||
| Prevalence and clinical correlates of explosive outbursts in Tourette syndrome | Q36527540 | ||
| Malignant Tourette syndrome | Q36848427 | ||
| Tourette syndrome in youth with and without obsessive compulsive disorder and attention deficit hyperactivity disorder | Q37043540 | ||
| New Insights into Clinical Characteristics of Gilles de la Tourette Syndrome: Findings in 1032 Patients from a Single German Center | Q37246824 | ||
| The prognosis of Tourette syndrome: implications for clinical practice | Q37267203 | ||
| The Gilles de la Tourette syndrome-quality of life scale (GTS-QOL): development and validation. | Q37310091 | ||
| Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders | Q37618812 | ||
| An Overview of the Treatment of Tourette's Disorder and Tics | Q37784214 | ||
| Clinical practice. Tourette's Syndrome | Q37818192 | ||
| Tourette syndrome: evolving concepts | Q37864240 | ||
| Canadian guidelines for the evidence-based treatment of tic disorders: behavioural therapy, deep brain stimulation, and transcranial magnetic stimulation | Q37991432 | ||
| The psychopathological spectrum of Gilles de la Tourette syndrome | Q38058162 | ||
| How does psychoeducation help? A review of the effects of providing information about Tourette syndrome and attention-deficit/hyperactivity disorder | Q38086571 | ||
| Herbal medicines for treating tic disorders: a systematic review of randomised controlled trials | Q38186155 | ||
| Mortality risk in a nationwide cohort of individuals with tic disorders and with tourette syndrome. | Q38401988 | ||
| Clonidine adhesive patch for the treatment of tic disorders: A systematic review and meta-analysis | Q38791317 | ||
| Tics and Tourette's: update on pathophysiology and tic control | Q38867076 | ||
| Temporal relationship between premonitory urges and tics in Gilles de la Tourette syndrome | Q39176016 | ||
| Predictors during childhood of future health-related quality of life in adults with Gilles de la Tourette syndrome | Q39645983 | ||
| Tourette syndrome associated with attention deficit hyperactivity disorder: The impact of tics and psychopharmacological treatment options | Q42545583 | ||
| Reliability and validity of the Mini International Neuropsychiatric Interview for Children and Adolescents (MINI-KID). | Q51777179 | ||
| A multicenter examination and strategic revisions of the Yale Global Tic Severity Scale. | Q52321953 | ||
| Determinants of quality of life in children with Gilles de la Tourette syndrome. | Q53110471 | ||
| [Diagnosis and treatment recommendations for tic disorders in children]. | Q53115682 | ||
| A Comprehensive Review of Tourette Syndrome and Complementary Alternative Medicine. | Q54915293 | ||
| Tic-related obsessive–compulsive disorder | Q58082625 | ||
| Why Chinese medicine is heading for clinics around the world | Q59099293 | ||
| Gilles de la Tourette Syndrome and Disruptive Behavior Disorders: Prevalence, Associations, and Explanation of the Relationships | Q60512592 | ||
| Gilles de la Tourette syndrome | Q62019874 | ||
| Clinical Features of Tourette Syndrome and Tic Disorders. | Q64911573 | ||
| Premonitory Urge for Tics Scale (PUTS): initial psychometric results and examination of the premonitory urge phenomenon in youths with Tic disorders | Q81607141 | ||
| [A multicenter controlled study on aripiprazole treatment for children with Tourette syndrome in China] | Q82552582 | ||
| Tic disorders | Q83187705 | ||
| Canadian guidelines for the evidence-based treatment of tic disorders | Q83591200 | ||
| Comparative Efficacy and Safety of Antipsychotic Drugs for Tic Disorders: A Systematic Review and Bayesian Network Meta-Analysis | Q87967626 | ||
| Pediatric neurology in China: challenges and solutions | Q89040710 | ||
| Compound-based Chinese medicine formula: From discovery to compatibility mechanism | Q89917235 | ||
| Prevalence and Clinical Correlates of Self-Harm Behaviors in Gilles de la Tourette Syndrome | Q90206495 | ||
| Revisiting the Efficacy and Tolerability of Topiramate for Tic Disorders: A Meta-Analysis | Q90454500 | ||
| Clinical Features of Tourette Syndrome | Q90685268 | ||
| Formulation and consideration of World Health Organization international classification of traditional medicine | Q90754643 | ||
| Tic disorders revisited: introduction of the term "tic spectrum disorders" | Q91126316 | ||
| Tourette disorder and other tic disorders | Q91284387 | ||
| Efficacy and safety of traditional Chinese medicine for Tourette's syndrome: A meta-analysis of randomized controlled trials | Q91297588 | ||
| Genetic Studies of Tic Disorders and Tourette Syndrome | Q91625760 | ||
| Tics and stereotypies: A comparative clinical review | Q91655440 | ||
| Progress in Pharmacological and Surgical Management of Tourette Syndrome and Other Chronic Tic Disorders | Q91692227 | ||
| Cerebrospinal fluid endocannabinoid levels in Gilles de la Tourette syndrome | Q91775177 | ||
| Practice guideline recommendations summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders | Q91803933 | ||
| Comprehensive systematic review summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders | Q91803939 | ||
| Genomic Relationships, Novel Loci, and Pleiotropic Mechanisms across Eight Psychiatric Disorders | Q91960472 | ||
| Interrogating the Genetic Determinants of Tourette's Syndrome and Other Tic Disorders Through Genome-Wide Association Studies | Q92016259 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 774 | |
| P577 | publication date | 2020-08-13 | |
| P1433 | published in | Frontiers in Psychiatry | Q27723495 |
| P1476 | title | Current Status, Diagnosis, and Treatment Recommendation for Tic Disorders in China | |
| P478 | volume | 11 |
Search more.